SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (3729)9/22/1997 1:45:00 PM
From: Rubble   of 3991
 
36 proved to be a critical point back in May. After passing 36 (pre), VVUS jumped to 42 in a single day. I think it was covering by all the people who shorted at the 35 point, held out when VVUS dropped to 30, and bailed out as the downtrend clearly reversed. This time, though there is a different group of shorts...probably ones with very deep pockets who shorted VVUS in the 60-80 (pre) range back in February and March. I think if we pass 40 the squeeze will start rolling. I also think the upcoming earnings report is giving the big shorters chronic insomnia. TA...if a patient complains to you about restlessness over then next few weeks, first ask if he's short VVUS...if he is, inform him that covering and then maybe picking up a few long shares should provide better relief than any medication. I've also heard staying short VVUS, especially so close to earnings, may contribute greatly to ED.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News